A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...

As CMS maintains limits on GLP-1 coverage for weight loss, new efficacy data and shifting prescribing patterns point to sustained high demand across the drug class. Here are four updates: 1. Federal ...

Although it isn't the largest therapeutic area in the pharmaceutical industry, the market for weight loss therapies has ...

A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

The results Lilly is reporting for its oral pill come as another big drug company, Pfizer, has decided to discontinue its ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...

Orforglipron, a new nonpeptide GLP-1 drug, may provide easier access for the treatment of Type 2 diabetes and obesity without ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight-loss drugs Ozempic and ...

Who could take the new weight-loss pill? In a nine-month trial on patients with type 2 diabetes, those on the highe ...

As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they ...